摘要:
Disclosed herein are compounds of the formula:
A-N(R¹)C(O)CH₂CHR²C(O)-B
wherein A is R³R⁴NC(O)CH₂ wherein, for example, R³ is hydrogen or alkyl and R⁴ is hydrogen, alkyl or a substituted alkyl such as 2-(2-pyridinyl)ethyl, or R³ and R⁴ together with the nitrogen atom to which they are attached form a pyrrolidino, piperidino, morpholino or thiomorpholino; R¹ is, for example, benzyl, alkyl or a substituted alkyl such as cyclohexylmethyl; R² is, for example, alkyl, cycloalkylmethyl, 1 H -imidazol-4-ylmethyl, 4-thiazolylmethyl or (2-amino-4-thiazolyl)methyl; and B is a renin substrate transition state analog, for example, [1(S)-(cyclohexylmethyl)-2(R),3(S)-dihydroxy-5-methylhexyl]amino. The compounds inhibit renin activity and are indicated for the treatment of hypertension and congestive heart failure.
摘要翻译:本文公开的是下式的化合物:AN(R 1)C(O)CH 2 CHR 2 C(O)-B,其中A是R 3 R 4 NC(O)CH 2,其中, R 3是氢或烷基,R 4是氢,烷基或取代的烷基如2-(2-吡啶基)乙基或R 3和R 4与它们所在的氮原子一起 连接形成吡咯烷子基,哌啶子基,吗啉代或硫代吗啉代; R 1是例如苄基,烷基或取代的烷基,例如环己基甲基; R 2是例如烷基,环烷基甲基,1H-咪唑-4-基甲基,4-噻唑基甲基或(2-氨基-4-噻唑基)甲基; B是肾素底物过渡态类似物,例如[1(S) - (环己基甲基)-2(R),3(S) - 二羟基-5-甲基己基]氨基。 该化合物抑制肾素活性,并被指示用于治疗高血压和充血性心力衰竭。